In the present study, by analyzing human and animal samples and applying different pharmacological and gain- and loss-of function experimental approaches, we conclude that LOX-induced oxidative stress seems to contribute to the procalcifying effects of this enzyme, which highlights the multifaceted role played by this family of enzymes in the pathophysiology of cardiovascular diseases. The gene discussed is LOX; the disease is cardiovascular disorder.